was read the article
array:24 [ "pii" => "S1579212918301769" "issn" => "15792129" "doi" => "10.1016/j.arbr.2018.06.002" "estado" => "S300" "fechaPublicacion" => "2018-08-01" "aid" => "1736" "copyright" => "SEPAR" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:431-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 748 "formatos" => array:3 [ "EPUB" => 95 "HTML" => 435 "PDF" => 218 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0300289617303186" "issn" => "03002896" "doi" => "10.1016/j.arbres.2017.08.017" "estado" => "S300" "fechaPublicacion" => "2018-08-01" "aid" => "1736" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2018;54:431-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1171 "formatos" => array:3 [ "EPUB" => 116 "HTML" => 744 "PDF" => 311 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Nódulos pulmonares cavitados en paciente tratada con anti-TNF" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "431" "paginaFinal" => "432" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Cavitating Pulmonary Nodules in a Patient Receiving Anti-TNF" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1466 "Ancho" => 3167 "Tamanyo" => 809330 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">TAC de tórax que muestra una lesión nodular cavitada en culmen (A) y otra en el segmento superior de la língula (B). C) Tinción de fibras elásticas para destacar la pared vascular arterial irregularmente destruida por el proceso inflamatorio. Se aprecia necrosis en el ángulo superior derecho. Orceina 200x.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Roberto Martín-de León, Jorge Moisés, Pilar Peris, Carlos Agustí, Ramón María Marrades" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Roberto" "apellidos" => "Martín-de León" ] 1 => array:2 [ "nombre" => "Jorge" "apellidos" => "Moisés" ] 2 => array:2 [ "nombre" => "Pilar" "apellidos" => "Peris" ] 3 => array:2 [ "nombre" => "Carlos" "apellidos" => "Agustí" ] 4 => array:2 [ "nombre" => "Ramón María" "apellidos" => "Marrades" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212918301769" "doi" => "10.1016/j.arbr.2018.06.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918301769?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303186?idApp=UINPBA00003Z" "url" => "/03002896/0000005400000008/v1_201808020445/S0300289617303186/v1_201808020445/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1579212918302416" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.10.032" "estado" => "S300" "fechaPublicacion" => "2018-08-01" "aid" => "1771" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Arch Bronconeumol. 2018;54:433-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 853 "formatos" => array:3 [ "EPUB" => 137 "HTML" => 522 "PDF" => 194 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Ground-glass Opacity Associated With Endobronchial Leech" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "433" "paginaFinal" => "434" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Opacidad de vidrio esmerilado asociada a una sanguijuela endobronquial" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2001 "Ancho" => 2000 "Tamanyo" => 313735 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Chest computed tomography showed a ground-glass opacity in the medial basal segment of the right lower lobe (A). Bronchoscopy revealed a brown worm-like moving foreign body almost completely obstructing the lumen of the medial basal segmental bronchus of the right lower lobe (B). The foreign body was identified as a 4<span class="elsevierStyleHsp" style=""></span>cm long living leech (C). Chest computed tomography after 1 week showed the ground-glass opacity in the right lower lobe was almost completely absorbed (D).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Zhong-Chuan Yang, Jiao Yang, Xu-Wei Wu, Xi-Qian Xing" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Zhong-Chuan" "apellidos" => "Yang" ] 1 => array:2 [ "nombre" => "Jiao" "apellidos" => "Yang" ] 2 => array:2 [ "nombre" => "Xu-Wei" "apellidos" => "Wu" ] 3 => array:2 [ "nombre" => "Xi-Qian" "apellidos" => "Xing" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0300289617304180" "doi" => "10.1016/j.arbres.2017.10.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617304180?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918302416?idApp=UINPBA00003Z" "url" => "/15792129/0000005400000008/v1_201808020514/S1579212918302416/v1_201808020514/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1579212918302404" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.10.031" "estado" => "S300" "fechaPublicacion" => "2018-08-01" "aid" => "1745" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Arch Bronconeumol. 2018;54:430" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 500 "formatos" => array:3 [ "EPUB" => 97 "HTML" => 243 "PDF" => 160 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical image</span>" "titulo" => "Primary Pleural Lymphoma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "430" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Linfoma pleural primario" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 492 "Ancho" => 2167 "Tamanyo" => 235295 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Chest CT (axial plan (AP)): extensive right pleural effusion conditioning almost complete atelectasis of the middle and lower lobes. No mediastinal or hilar pulmonary lymphadenopathies were found. (B) Medical thoracoscopy: pericentrimetric macular lesions with multifocal distribution and stony consistency. (C) Small to intermedium lymphocytes with nuclear irregularity, admixed with mesothelial cells, H&E 400í. (D) Diffuse expression of CD20 in the neoplastic cells, 400í.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Filipa Ramalho Fernandes, Rui Caetano Oliveira, Luís Vaz Rodrigues" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Filipa Ramalho" "apellidos" => "Fernandes" ] 1 => array:2 [ "nombre" => "Rui Caetano" "apellidos" => "Oliveira" ] 2 => array:2 [ "nombre" => "Luís Vaz" "apellidos" => "Rodrigues" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0300289617303915" "doi" => "10.1016/j.arbres.2017.10.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303915?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918302404?idApp=UINPBA00003Z" "url" => "/15792129/0000005400000008/v1_201808020514/S1579212918302404/v1_201808020514/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Cavitating Pulmonary Nodules in a Patient Receiving Anti-TNF" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "431" "paginaFinal" => "432" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Roberto Martín-de León, Jorge Moisés, Pilar Peris, Carlos Agustí, Ramón María Marrades" "autores" => array:5 [ 0 => array:3 [ "nombre" => "Roberto" "apellidos" => "Martín-de León" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Jorge" "apellidos" => "Moisés" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Pilar" "apellidos" => "Peris" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Carlos" "apellidos" => "Agustí" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:4 [ "nombre" => "Ramón María" "apellidos" => "Marrades" "email" => array:1 [ 0 => "marrades@clinic.cat" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servei de Pneumologia i Al·lèrgia, Institut Clínic Respiratori, Hospital Clínic de Barcelona, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servei de Reumatologia, Institut Clínic d’Especialitats Mèdiques i Quirúrgiques, Hospital Clínic de Barcelona, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nódulos pulmonares cavitados en paciente tratada con anti-TNF" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1466 "Ancho" => 3167 "Tamanyo" => 810269 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Chest CT showing a cavitating nodular lesion in the left upper lobe and (B) another in the upper segment of the lingula. (C) Staining of elastic fibers to highlight the irregular destruction of the arterial wall by the inflammatory process. Necrosis is seen in the upper right corner. Orcein 200×.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The development of biologics has led in recent years to a breakthrough in the treatment of chronic inflammatory joint disease, especially rheumatoid arthritis (RA). This group of drugs includes tumor necrosis factor (TNFα) inhibitors, which have proven efficacy in the treatment of this disease.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">1</span></a> TNFα inhibitors are generally well tolerated and show an acceptable safety profile. However, the inhibition of TNFα, a cytokine that plays an essential role in inflammation and response to infection, has been associated with an increased likelihood of infectious complications.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">2</span></a> Reports have also emerged in the last 10 years of non-infectious systemic and pulmonary side effects, including malignancies<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">3</span></a> and secondary autoimmune disorders.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">We report the case of a 62-year-old woman, former smoker of 15 pack-years, with a 10-year history of palindromic rheumatism that progressed to RA with bone erosion. She received treatment with various disease-modifying antirheumatic drugs (DMARD), such as hydroxychloroquine sulfate, methotrexate, and gold salts, together with NSAIDs (indomethacin and naproxen) and low-dose prednisone, depending on her symptoms, at different disease stages.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Between May 2010 and March 2012, due to a lack of response to DMARDs, she received biological treatment with anti-TNFα (etanercept) for the first time, with improvement of her joint symptoms. In March 2016, when she was receiving treatment with methotrexate (20<span class="elsevierStyleHsp" style=""></span>mg/week) for a new flare, etanercept was reintroduced (50<span class="elsevierStyleHsp" style=""></span>mg/week), again resulting in clinical improvement.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In a radiological follow-up of the disease, when the patient was asymptomatic, a chest X-ray and computed tomography (CT) were obtained, showing 2 solid cavitating nodules, one measuring 15<span class="elsevierStyleHsp" style=""></span>mm in the apicoposterior segment of the left upper lobe (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A) and the other 24<span class="elsevierStyleHsp" style=""></span>mm in the upper segment of the lingula (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Laboratory tests, including complete blood count, coagulation, blood biochemistry, and tumor markers, were normal. CRP and ESR were 0.42<span class="elsevierStyleHsp" style=""></span>ng/dl and 27<span class="elsevierStyleHsp" style=""></span>mm/h, respectively. Autoimmune tests showed elevated cyclic citrullinated peptide antibodies (381<span class="elsevierStyleHsp" style=""></span>IU) and rheumatoid factor (200<span class="elsevierStyleHsp" style=""></span>IU), with values similar to previous determinations. Basic urine profile showed no significant changes. Serum anti-neutrophil cytoplasmic antibodies determined by immunofluorescence were negative, as was ELISPOT-TB.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Fiberoptic bronchoscopy was performed, showing no endobronchial abnormalities, and microbiological and cytological studies of the bronchial aspirate and bronchoalveolar lavage were negative.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Positron emission tomography was also performed, showing annular, irregular 18F-fluorodeoxyglucose uptake limited to the pulmonary nodules, with a SUVmax of 2.9 in the lesion located in the left upper lobe and 3.1 in the lesion located in the lingula.</p><p id="par0040" class="elsevierStylePara elsevierViewall">A pulmonary biopsy was obtained from the lingular lesion using CT-guided Tru-Cut. Histopathological study showed a granulomatous inflammatory lesion associated with vasculitis consistent with granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C).</p><p id="par0045" class="elsevierStylePara elsevierViewall">In view of the diagnostic suspicion of granulomatosis with polyangiitis associated with the administration of etanercept, this drug was discontinued and treatment began with prednisone 1<span class="elsevierStyleHsp" style=""></span>mg/kg/day in a tapering regimen, and the background biological treatment was replaced by tocilizumab (8<span class="elsevierStyleHsp" style=""></span>mg/kg/month). Chest CT 3 months later showed resolution of the lesions.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The exclusion of other pulmonary complications, the temporal association with the administration of etanercept, and the rapid and complete resolution of the pulmonary lesions after its withdrawal and subsequent treatment with corticosteroids confirm the diagnosis of vasculitis associated with etanercept.</p><p id="par0055" class="elsevierStylePara elsevierViewall">The spectrum of pulmonary manifestations of RA is wide and includes involvement of the parenchyma (interstitial lung disease, pulmonary nodules), airway (bronchiolitis obliterans, bronchiectasis), pleura (effusion, bronchopleural fistula, pneumothorax), and the pulmonary vasculature (pulmonary hypertension, thromboembolic disease), that may precede joint symptoms in 10%–20% of cases.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">6</span></a> This case shows that the differential diagnosis must also include side effects of immunomodulatory therapy (toxicity, infection) used in the treatment of these patients.</p><p id="par0060" class="elsevierStylePara elsevierViewall">The mechanisms causing anti-TNFα to trigger antibody formation and autoimmune processes are not fully clarified. There is evidence that treatment with anti-TNFα is associated with a higher production of antinuclear antibodies, depending on the type of anti-TNFα used. In the case of etanercept, antinuclear antibody levels range from 11% to 54%,<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">7–9</span></a> and this has also been associated with the development of other autoimmune diseases, such as leukocytoclastic vasculitis, accelerated rheumatoid nodulosis, and vasculitis associated with anti-neutrophil cytoplasmic antibodies.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">10</span></a> Clinical manifestations are variable, and patients, like ours, often have no associated systemic symptoms. Vasculitis associated with anti-TNFα therapy is a rare complication, and in most cases the presentation is exclusively cutaneous<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">11</span></a>; pulmonary involvement in these patients is unusual. Ramos-Casals et al. reported a series of 233 patients with anti-TNFα-induced autoimmune diseases, including 133 cases of vasculitis. Of these, only 3 were pulmonary (3%).<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">12</span></a> Treatment consisted of discontinuing the drug and administering corticosteroids.</p><p id="par0065" class="elsevierStylePara elsevierViewall">In conclusion, while anti-TNFα offers clear advantages in the management of RA, these biologics should be used with caution and under close monitoring, particularly in patients with pre-existing lung disease.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">13</span></a> If lesions and/or pulmonary infiltrates develop during treatment with anti-TNFα the first step is to rule out infectious processes. If results are inconclusive, infiltrates are persistent, and the index of suspicion is high, invasive tests such as transbronchial biopsy, cryobiopsy, CT-guided biopsy, or even surgical biopsy are recommended in order to obtain a definitive diagnosis and to indicate the correct treatment.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Martín-de León R, Moisés J, Peris P, Agustí C, Marrades RM. Nódulos pulmonares cavitados en paciente tratada con anti-TNF. Arch Bronconeumol. 2018;54:431–432.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1466 "Ancho" => 3167 "Tamanyo" => 810269 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Chest CT showing a cavitating nodular lesion in the left upper lobe and (B) another in the upper segment of the lingula. (C) Staining of elastic fibers to highlight the irregular destruction of the arterial wall by the inflammatory process. Necrosis is seen in the upper right corner. Orcein 200×.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:13 [ 0 => array:3 [ "identificador" => "bib0070" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Biologics for rheumatoid arthritis: an overview of Cochrane reviews (Review)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Singh" 1 => "R. Christensen" 2 => "G.A. Wells" 3 => "M.E. Suarez-Almazor" 4 => "R. Buchbinder" 5 => "M.A. Lopez-Olivo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2009" "volumen" => "4" "paginaInicial" => "CD007848" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0075" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Infections associated with tumor necrosis factor-alpha antagonists" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.J. Rychly" 1 => "J.T. DiPiro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1592/phco.2005.25.9.1181" "Revista" => array:6 [ "tituloSerie" => "Pharmacotherapy" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "1181" "paginaFinal" => "1192" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16164393" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0080" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Bongartz" 1 => "A.J. Sutton" 2 => "M.J. Sweeting" 3 => "I. Buchan" 4 => "E.L. Matteson" 5 => "V. Montori" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.295.19.2275" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2006" "volumen" => "295" "paginaInicial" => "2275" "paginaFinal" => "2285" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16705109" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0085" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "N. Scheinfeld" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/09546630410017275" "Revista" => array:6 [ "tituloSerie" => "J Dermatolog Treat" "fecha" => "2009" "volumen" => "15" "paginaInicial" => "280" "paginaFinal" => "294" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15370396" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0090" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary complications of tumor necrosis factor-targeted therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "K. Thavarajah" 1 => "P. Wu" 2 => "E.J. Rhew" 3 => "A.K. Yeldandi" 4 => "D.W. Kamp" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rmed.2009.01.002" "Revista" => array:6 [ "tituloSerie" => "Respir Med" "fecha" => "2009" "volumen" => "103" "paginaInicial" => "661" "paginaFinal" => "669" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19201589" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0095" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rheumatoid arthritis (RA) associated interstitial lung disease (ILD)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D.N. O’Dwyer" 1 => "M.E. Armstrong" 2 => "G. Cooke" 3 => "J.D. Dodd" 4 => "D.J. Veale" 5 => "S.C. Donnelly" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejim.2013.07.004" "Revista" => array:6 [ "tituloSerie" => "Eur J Intern Med" "fecha" => "2013" "volumen" => "24" "paginaInicial" => "597" "paginaFinal" => "603" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23916467" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0100" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Biological and clinical effects of anti-TNFα treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G. Valesini" 1 => "C. Iannuccelli" 2 => "E. Marocchi" 3 => "L. Pascoli" 4 => "V. Scalzi" 5 => "M. di Franco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.autrev.2007.03.003" "Revista" => array:6 [ "tituloSerie" => "Autoimmun Rev" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "35" "paginaFinal" => "41" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17967723" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0105" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug-induced systemic lupus erythematosus associated with etanercept therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N. Shakoor" 1 => "M. Michalska" 2 => "C.A. Harris" 3 => "J.A. Block" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(02)07714-0" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2002" "volumen" => "359" "paginaInicial" => "579" "paginaFinal" => "580" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11867114" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0110" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-TNFα therapy in rheumatoid arthritis and autoimmunity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Caramaschi" 1 => "D. Biasi" 2 => "M. Colombatti" 3 => "S. Pieropan" 4 => "N. Martinelli" 5 => "A. Carletto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00296-004-0542-1" "Revista" => array:6 [ "tituloSerie" => "Rheumatol Int" "fecha" => "2004" "volumen" => "26" "paginaInicial" => "209" "paginaFinal" => "214" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15627197" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0115" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "T.W.R. Doulton" 1 => "B. Tucker" 2 => "J. Reardon" 3 => "N. Velasco" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Nephrol" "fecha" => "2004" "volumen" => "62" "paginaInicial" => "234" "paginaFinal" => "238" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15481857" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0120" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vasculitis associated with tumor necrosis factor-α inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "O. Sokumbi" 1 => "D.A. Wetter" 2 => "A. Makol" 3 => "K.J. Warrington" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.mayocp.2012.04.011" "Revista" => array:6 [ "tituloSerie" => "Mayo Clin Proc" "fecha" => "2012" "volumen" => "87" "paginaInicial" => "739" "paginaFinal" => "745" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22795634" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0125" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autoimmune diseases induced by TNF-targeted therapies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Ramos-Casals" 1 => "P. Brito-Zerón" 2 => "S. Muñoz" 3 => "N. Soria" 4 => "D. Galiana" 5 => "L. Bertolaccini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MD.0b013e3181441a68" "Revista" => array:6 [ "tituloSerie" => "Medicine" "fecha" => "2007" "volumen" => "86" "paginaInicial" => "242" "paginaFinal" => "251" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17632266" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0130" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Perez-Alvarez" 1 => "M. Perez-de-Lis" 2 => "C. Diaz-Lagares" 3 => "J.M. Pego-Reigosa" 4 => "S. Retamozo" 5 => "A. Bove" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.semarthrit.2010.11.002" "Revista" => array:6 [ "tituloSerie" => "Semin Arthritis Rheum" "fecha" => "2011" "volumen" => "41" "paginaInicial" => "256" "paginaFinal" => "264" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21277618" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005400000008/v1_201808020514/S1579212918301769/v1_201808020514/en/main.assets" "Apartado" => array:4 [ "identificador" => "49861" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005400000008/v1_201808020514/S1579212918301769/v1_201808020514/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918301769?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 6 | 5 | 11 |
2024 October | 59 | 21 | 80 |
2024 September | 57 | 15 | 72 |
2024 August | 86 | 53 | 139 |
2024 July | 62 | 22 | 84 |
2024 June | 78 | 46 | 124 |
2024 May | 81 | 29 | 110 |
2024 April | 51 | 28 | 79 |
2024 March | 46 | 21 | 67 |
2024 February | 35 | 17 | 52 |
2023 March | 19 | 9 | 28 |
2023 February | 60 | 17 | 77 |
2023 January | 62 | 36 | 98 |
2022 December | 80 | 27 | 107 |
2022 November | 118 | 25 | 143 |
2022 October | 103 | 27 | 130 |
2022 September | 111 | 34 | 145 |
2022 August | 82 | 37 | 119 |
2022 July | 62 | 45 | 107 |
2022 June | 62 | 38 | 100 |
2022 May | 70 | 61 | 131 |
2022 April | 88 | 47 | 135 |
2022 March | 92 | 51 | 143 |
2022 February | 77 | 25 | 102 |
2022 January | 99 | 41 | 140 |
2021 December | 80 | 45 | 125 |
2021 November | 55 | 46 | 101 |
2021 October | 99 | 42 | 141 |
2021 September | 66 | 50 | 116 |
2021 August | 58 | 40 | 98 |
2021 July | 75 | 21 | 96 |
2021 June | 77 | 38 | 115 |
2021 May | 62 | 53 | 115 |
2021 April | 114 | 95 | 209 |
2021 March | 69 | 17 | 86 |
2021 February | 33 | 22 | 55 |
2021 January | 42 | 17 | 59 |
2020 December | 42 | 23 | 65 |
2020 November | 49 | 17 | 66 |
2020 October | 133 | 20 | 153 |
2020 September | 106 | 10 | 116 |
2020 August | 30 | 13 | 43 |
2020 March | 18 | 5 | 23 |
2020 February | 35 | 14 | 49 |
2020 January | 49 | 10 | 59 |
2019 December | 42 | 15 | 57 |
2019 November | 21 | 13 | 34 |
2019 October | 26 | 14 | 40 |
2019 September | 34 | 10 | 44 |
2019 August | 24 | 11 | 35 |
2019 July | 19 | 11 | 30 |
2019 June | 33 | 10 | 43 |
2019 May | 42 | 18 | 60 |
2019 April | 43 | 56 | 99 |
2019 March | 43 | 22 | 65 |
2019 February | 30 | 15 | 45 |
2019 January | 3 | 4 | 7 |